Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers
Open Access
- 1 December 2002
- journal article
- clinical trial
- Published by Springer Nature in AAPS PharmSci
- Vol. 4 (4) , 29-38
- https://doi.org/10.1208/ps040422
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Population Pharmacokinetics and Pharmacodynamic Modeling of Abacavir (1592U89) from a Dose-Ranging, Double-Blind, Randomized Monotherapy Trial with Human Immunodeficiency Virus-Infected SubjectsAntimicrobial Agents and Chemotherapy, 2000
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Neuraminidase Inhibitors as Anti-Influenza Virus AgentsAntiviral Chemistry and Chemotherapy, 1999
- New Approaches to Influenza ChemotherapyDrugs, 1998
- Stability and Performance of a Population Pharmacokinetic ModelThe Journal of Clinical Pharmacology, 1997
- Population Pharmacokinetic Modeling: The Importance of Informative GraphicsPharmaceutical Research, 1995
- Pharmacodynamics of Antiretroviral ChemotherapyInfection Control & Hospital Epidemiology, 1993
- Pharmacodynamics of Antiretroviral ChemotherapyInfection Control & Hospital Epidemiology, 1993
- PharmacokineticsPublished by Taylor & Francis ,1982
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981